Since TPP2 regulates cancer cell immunogenicity by degrading antigenic peptides, it can be inferred and experimentally verified that mitochondrial fission inhibition would not affect the expression of other immunological-related or unrelated transmembrane proteins (Fig. 7F). This evidence concerns the gene TPP2 and cancer.